BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 750125)

  • 1. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
    Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
    Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
    [No Abstract]   [Full Text] [Related]  

  • 2. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R; Urban K
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract]   [Full Text] [Related]  

  • 3. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
    Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
    J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNCB-skin specimens for immunodiagnosis].
    Sinn W
    Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the DNCB skin test in patients with solid neoplasms].
    Mor C; Marcovina S; Moro E; Radice F; Russo R; Trinca E
    Arch Sci Med (Torino); 1978; 135(3):377-82. PubMed ID: 708088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNCB and PPD skin testing in breast cancer.
    Munzarová M; Kovarík J; Ninger E; Zemanová D; Lauerová L; Kolcová V; Hlávková J; Pacovský Z
    Neoplasma; 1983; 30(4):385-9. PubMed ID: 6888607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cellular mediated immunity in a normal adult population.
    Robert F; Lozada JA; Muñiz FJ
    Bol Asoc Med P R; 1977 Feb; 69(2):64-9. PubMed ID: 265703
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vitro method for assaying sensitivity to 2,4-dinitrochlorobenzene (DNCB) in man.
    Whitehead RH; Bolton PM; James SL; Roberts GM
    Eur J Cancer (1965); 1974 Nov; 10(11):721-4. PubMed ID: 4469495
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
    Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
    Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "DNCB reactivity in cancer patients and during follow-up period".
    Hardas UD; Jalgaonkar SV
    Indian J Cancer; 1982; 19(5):260-2. PubMed ID: 7166344
    [No Abstract]   [Full Text] [Related]  

  • 14. [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
    Bianucci P; Pastorino G; Brondi P
    Minerva Med; 1982 Oct; 73(41):2891-5. PubMed ID: 7133502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic implications of cellular immune defects in operable cancer patients revealed by dinitrochlorobenzene skin contact sensitivity.
    Ketcham AS; Chretien PB
    Panminerva Med; 1975; 17(5-6):174-8. PubMed ID: 1057759
    [No Abstract]   [Full Text] [Related]  

  • 16. [DNCB test and immune competence. Analysis of patients with urologic neoplasms].
    Klippel KF; Walz HP; Kreutz G; von Moltke T
    MMW Munch Med Wochenschr; 1978 Aug; 120(31):1027-8. PubMed ID: 308155
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
    Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.
    Walewski J; Nowakowska A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):29-33. PubMed ID: 7283677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigens.
    Thompson CD; Whittingham S; Mackay IR; Khoo SK; Toh BH; Stagg RJ
    Can Med Assoc J; 1975 May; 112(9):1078-81. PubMed ID: 1079163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.